THE KINETIC CHARACTERIZATION OF TWO PUTATIVE GALACTOSIDASES, BT2857 AND SCO6594, AND THE PRELIMINARY ANALYSES OF SCO6595-97 by Ngo, Maria
Wilfrid Laurier University 
Scholars Commons @ Laurier 
Theses and Dissertations (Comprehensive) 
2016 
THE KINETIC CHARACTERIZATION OF TWO PUTATIVE 
GALACTOSIDASES, BT2857 AND SCO6594, AND THE 
PRELIMINARY ANALYSES OF SCO6595-97 
Maria Ngo 
Wilfrid Laurier University, ngox8930@mylaurier.ca 
Follow this and additional works at: https://scholars.wlu.ca/etd 
 Part of the Biochemistry Commons 
Recommended Citation 
Ngo, Maria, "THE KINETIC CHARACTERIZATION OF TWO PUTATIVE GALACTOSIDASES, BT2857 AND 
SCO6594, AND THE PRELIMINARY ANALYSES OF SCO6595-97" (2016). Theses and Dissertations 
(Comprehensive). 1855. 
https://scholars.wlu.ca/etd/1855 
This Thesis is brought to you for free and open access by Scholars Commons @ Laurier. It has been accepted for 
inclusion in Theses and Dissertations (Comprehensive) by an authorized administrator of Scholars Commons @ 
Laurier. For more information, please contact scholarscommons@wlu.ca. 
 THE KINETIC CHARACTERIZATION OF TWO 
PUTATIVE GALACTOSIDASES, BT2857 AND 







Submitted to the Department of Chemistry and Biochemistry 
Faculty of Science 
In partial fulfillment of the requirements for the 
Master of Science in Chemistry and Biochemistry 
Wilfrid Laurier University 
2016 
 




Bacteroides thetaiotaomicron is a prolific bacterium found in the distal intestinal 
tract of humans that possesses the ability to breakdown complex polysaccharides through 
the release of carbohydrate-active enzymes (CAZymes). Overall, the saccharolytic 
prowess of B. thetaiotaomicron presents an intriguing model for understanding 
microbial-host nutrient exchange within the gut and to identify novel mechanisms for 
accessing carbohydrates.  The successful expression, purification, and preliminary kinetic 
characterization of BT2857 are reported. BT2857 was found to be enzymatically active 
against the artificial substrate, 4-nitrophenyl β-D-galactopyranoside (pNP-Gal); 
suggesting its role as a putative β-galactosidase and allowed for the quantification of 
BT2857 activity by the determination of the Michaelis-Menten parameters kcat, KM, and 
Vmax. A combinatorial molecular modeling approach of genomic context predicted a two-
domain structure formed primarily of beta-sheets and loops. Polysaccharide Utilization 
Loci (PUL) analysis revealed BT2851-55 collectively belonging to GH36, GH42, GH3 
and GH2 providing insight on potential substrates downstream from BT2857. The natural 
substrate remains unknown despite experiments demonstrating the upregulation of this 
region of the B.thetaiotaomicron genome in the presence of varying carbohydrates. 
Crystallization of the truncations of BT2857 will be a key finding for structure and 
functional characterization.  
Streptomyces coelicolor is the representative species within its genus and 
predominantly found in soil with access to a diverse environment of carbohydrate sources. 
The main contribution of S. coelicolor is the metabolism of insoluble remains from plants 
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and animals indicating positive improvements on plant growth and the rhizosphere. To 
date, the kinetic characterization of a putative galactosidase, SCO6594 has been explored 
including the determination of Michaelis-Menten parameters. Solubility screening of 
SCO6595-67 also display potential expression and characterization of this gene cluster 
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CHAPTER 1 – INTRODUCTION 
1.1 Glycobiology and Carbohydrate Variance 
Carbohydrates also referred to as saccharides or sugars, are molecules that 
commonly feature in biosynthetic processes or as structural components for the cell [9]. 
They are arranged in over a million different isomers with variation in stereochemistry 
and are a crucial source of energy [10,11]. Carbohydrates are found throughout the 
cellular surface, within the extracellular matrix, and covalently bound to form 
glycoproteins; thus offering roles that span from the growth and function of cellular 
processes to adhesion and recognition for cell-cell interactions [12]. Oligosaccharides and 
polysaccharides are used in microbial interactions in living organisms including the 
storage of energy, as signal molecules in specific processes, the production of the cell 
wall, and much more [10,13]. The utilization of carbohydrates by bacteria have a crucial 
role as a source of energy and as a key constituent of the peptidoglycan which is made up 
of alternating units of N-acetyl glucosamine and N-acetyl muramic acid that forms the 
cell wall [14,15]. Oligosaccharides of collagen also have a role in the stability and 
physical condition of human tissue serving as a scaffold [12]. Overall, there are many 
processes and interactions (cell-cell, cell-carbohydrate, etc.) that are modulated by the 
presence of carbohydrates [16,17]. An example demonstrating the dependence of 
carbohydrate-protein interaction is the recognition of mannose-6-phosphate to initiate the 
exportation of lysosomal enzymes from the Golgi apparatus [18]. Moreover, 
carbohydrates are not only valuable as free-standing compounds, but also when they are 
covalently attached to secreted proteins or part of the cell surface [19]. The carbohydrate 
moiety of glycosylated proteins typically contribute to recognition and modification in 
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biological systems [12,20]. Over the years, the biotechnology industry has evolved 
towards the engineering of therapeutic glycoproteins such as enzymes, hormones and 
antibodies [21,22]. Although there are many advantages in the glycosylation of proteins, 
not all modifications are beneficial. In a study with bone and platelet osteonectin, it was 
revealed that the collagen-binding properties of the protein was altered after 
glycosylation [23]. Furthermore, granted that carbohydrates and glycosylation present 
many benefits, they are often found in complex forms or as bulky polysaccharides which 
make them unfavorable for cellular transportation [24]. Hence, the breakdown of 
complex carbohydrates by carbohydrate-active enzymes help release simpler forms of 
sugars (i.e. glucose, fructose, galactose) beneficial for situations like absorption by the 
host organism in symbiotic situations later discussed in the human gut microbiome 
[25,26].  
1.2 Carbohydrate-Active Enzymes 
Carbohydrate-active enzymes (CAZymes) utilize carbohydrates as substrate for 
metabolic processes involving the breakdown and synthesis of glycosidic bonds to form 
simple or complex sugars [27]. CAZymes are organized into classes and families based 
on sequence similarity with established groups of characterized proteins, therein 
providing inferences to structure and function by using a combination of predictive 
software [28]. The CAZy database (http://www.cazy.org/) serves as a guide by 
organizing sequences that encode for putative CAZymes or proteins that possess 
carbohydrate-binding modules (CBMs). Although this is a useful starting point, common 
research questions arise from the variance in substrate specificity even among enzymes of 
the same family. Therefore, a combination of glycogenomics with experimental 
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procedures is required for complete protein characterization. The classes of CAZymes 
that can be found in the CAZy database are glycoside hydrolases (GHs), 
glycosyltransferases (GTs), polysaccharide lyases (PLs), carbohydrate esterases (CEs), 
and auxiliary activities (AAs) [28]. Glycoside hydrolases (also referred to as glycosidases 
or glycosyl hydrolases) catalyze glycosidic bonds with the involvement of activated 
water molecules [29]. Glycosyltransferases catalyse the transfer of a sugar moiety to an 
acceptor molecule through the formation of a glycosidic bond [30]. Glycosyltransferases 
are commonly used in drug discovery and development for targeted drug delivery [20]. In 
general, glycosylation is also found to contribute to protein folding and transportation 
across the cell membrane [31]. Polysaccharide lyases perform similar reactions to 
glycoside hydrolases but differ in the absence of water to break glycosidic bonds [32]. 
The reaction by carbohydrate esters is unique from the other enzyme classes because the 
products result in a carboxylic acid and unlike the rest of the CAZymes, cleaves an ester 
bond rather than a glycosidic bond [27,33]. Finally, auxiliary activities are a family 
classified in connection with CAZymes involved in redox reactions [28]. An example of 
an auxiliary activity is the characterization of a protein as a mono-oxygenase belonging 
to GH61 [34]. Additionally, carbohydrate-binding modules (CBMs) are frequently 
associated with the catalytic domains of CAZymes but are not enzymatically-active 
themselves [34,35]. CBMs increase enzymatic activity by anchoring long-chain 
carbohydrates to increase the proximity of the substrate from the enzymatic domain [36]. 
Overall, CAZymes have demonstrated their usefulness in the metabolism of 
carbohydrates. In particular, bacteria are known to code for a large number of CAZymes 
that enable them to adapt to different environments and selection of carbohydrate sources 
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available [27,37]. Harnessing the activity from CAZymes have value in therapeutic 
applications of disease research as well as large-scale production of alternative biomass 
resources [38]. For instance, ethanol and butanol can be produced through the 
fermentation of monosaccharides released from GH activity of degraded cellulose 
providing potential for the growing market of flexible fuel vehicles [38]. Furthermore, 
understanding the mechanisms of such CAZymes can either be improved for increased 
efficiency (i.e.biofuel production) or restricted for inhibitory effects. The latter situation 
is advantageous when studying CAZymes involved in disease such as the involvement of 
glycosidases in the virulence of Streptococcus pneumoniae [39]. Site-directed 
mutagenesis of conserved catalytic residues is a useful technique for manipulating the 
kinetic activity of such enzymes [40]. In general, CAZymes have demonstrated 
expression in a widespread number of bacteria and allow for an understanding between 
the effect of carbohydrates and their local environments as well as the microbial 
processes of the species.  
1.2.1 Focus on Glycoside Hydrolases 
 Of the CAZyme classes mentioned, glycoside hydrolases arises as the most 
common domain among the putative proteins addressed throughout this project. 
Glycoside hydrolases (GHs) are a group of enzymes that cleave the glycosidic bond via 
general acid/base catalysis [41]. There are two described catalytic mechanism of GHs, 
retaining or inverting GHs, and both involve a Bronsted acid and Lewis base (Figure 1) 
[10]. In retaining GHs, the Lewis base (B
-
) directly attacks the O-glycosidic bond and 
deprotonates the acidic (AH) residue to release the product. A water molecule is then 
deprotonated by the free acid (A
-
) from above to hydrolyze the bond between the Lewis 
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base and the remaining glycosyl compound resulting in retention of stereochemistry [10]. 
In inverting GHs, the Lewis base (B
-
) activates a water molecule for hydrolysis of the O-
glycosidic bond from below. The catalytic acid (AH) simultaneously protonates the 
glycosidic oxygen of the leaving group which results in the inversion of the glycoside 
stereochemistry [10].  
 
Figure 1. Mechanism of (A) retaining and (B) inverting glycoside hydrolases: (A) 
The Lewis base (B
-
) directly attacks the anomeric carbon and the Bronsted acid (AH) 
protonates the leaving group. The Bronsted acid (A
-
) activates a water molecule which 
hydrolyzes the bond between the base and substrate also reversing the stereochemistry to 
the original direction. (B) The Lewis base (B
-
) activates a water molecule for hydrolysis 
thus inverting the substrate stereochemistry. The leaving group is protonated by the 
Bronsted acid (AH). 
 
Other than the step-wise differences in the two mechanisms, there is also a 5.5Å and 10Å 
spatial difference between catalytic residues for retaining and inverting GHs, respectively 
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[42]. Up to date, there are 131 families of GHs in which evolutionary divergence can be 
observed through differences in substrate specificity within the same family [10]. Studies 
have also shown mechanistic development in GHs by manipulating the substrate into a 
“half-chair” or “sofa” conformation thus lowering the activation energy for catalysis [43]. 
Additionally, aspartate and glutamate residues are commonly known as the acid/base pair 
for catalysis, however other residues such as tyrosine was also found to play a role in 
stabilization of the transitional state of the substrate in retaining mechanisms [44,45].  
 Aside all the mechanistic developments amongst GH families, the active-site 
topology of this enzyme class categorizes into three types of general folds (Figure 2):  
1. The pocket or crater proteins possess an active site that is buried within the core 
of the protein and envelopes the substrate. The pocket/crater shape is most ideal 
for exo-acting enzymes and monosaccharidases because of the limiting space of 
the enclosed active site. A model example of a pocket/crater protein is 
glucoamylasae from Aspergillus awamori (PDB ID: 1GLM) [46]. 
Polysaccharides with branched composition such as starch and amylopectin are 
common substrates for pocket/crater GHs because of their abundance in non-
reducing free ends.  
2. The cleft or groove proteins are endo-acting enzymes that more optimal for less 
fibrous substrates such as cellulose and chitin due to the nature of the U-shaped 
fold exposing the active site to the surroundings. An example of a cleft/groove 
protein is endoglucanase Cel6A from Thermobifida fusca (PDB ID: 2BOD) [47]. 
3. The tunnel proteins are enzymatically efficient for releasing cellobiose from 
cellulose as the substrate remains bound while the free end is fed through (as the 
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name suggests) the active site. Thus far, the only characterized GH with a tunnel 
fold is cellobiohydrolase Cel6A and Cel7A from Trichoderma reesei (PDB ID: 
3CBH) [48,49].    
 
Figure 2. Surface models of GH active-site topologies for (A) pocket or crater, (B) 
cleft or groove, and (C) tunnel proteins: (A) The active site (blue) of pocket/crater 
proteins are buried within the protein and is typical for exo-acting enzymes. (B) The 
active site (blue) of cleft/groove proteins are exposed to the solvent and are most optimal 
for rigid substrates with less free ends such as cellulose and chitin. (C) 
Cellobiohydrolyase Cel6A and Cel7A from T. reesei (PDB ID: 3CBH) is the only GH 
observed with a tunnel fold (circled in red) and is useful for catalyzing long 
polysaccharides.  
 
1.3 The Human Gut Microbiome and Carbohydrate-Processing 
The human gut microbiome consists of tens of trillions of microorganisms with 
anaerobic species outnumbering aerobic species by nearly one thousand to one, and 
demonstrate mutualistic and commensialistic relationships [50–52]. Because of the 
beneficial health implications of probiotic supplements, dietary additives containing 
specific carbohydrates have been developed to attempt to manipulate the gut metabolism 
[53]. The gut microbiota consists of approximately 400 different species of bacteria; 
A)                          B)     
   C) 
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however 70% of the population is accounted by species belonging to the genera 
Cytophaga, Flavobacterium, Firmicutes, and Bacteroides. Of the dominating genera, 
Bacteroides makes up 25% of that population [54]. The presence of such bacteria is key 
to the metabolism of dietary carbohydrates, because the human genome only codes for 17 
CAZymes that are involved in digestion of foods containing starch, sucrose and lactose 
[25,50,55]. Therefore, the gut microbiota aid in metabolic activities with their wide 
production of enzymes that otherwise are not encoded by the human genome [50]. The 
evolution of the gut microbiota has demonstrated many benefits including the protection 
against pathogenic micro-organisms by triggering the human immune system, and most 
importantly the degradation of complex carbohydrates which is beneficial for  intestinal 
absorption [50].  
1.3.1 Bacteroides thetaiotaomicron 
Bacteroides thetaiotaomicron is localized in the descending (or distal) large 
intestine and currently codes for approximately 300 CAZymes with a total of 55 GH and 
PL families, and 172 characterized GHs [50,53,56]. Its genome encodes for the most 
number of genes involved in carbohydrate metabolism including two notable outer 
membrane proteins, SusC and SusD, responsible for the transportation and binding of 
starch [57]. B. thetaiotaomicron produces approximately 11% of extracellular targeted 
CAZymes that are involved in the breakdown of indigestible polysaccharides ( i.e. 
cellulose) thus leaving monosaccharides and disaccharides to be absorbed in the small 
intestine [56]. As mentioned earlier, one benefit of carbohydrate use by B. 
thetaiotaomicron is the formation of an intestinal mucosal barrier that induces the release 
of angiogenin to support the human immune response against pathogenic microorganisms 
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[58]. Another intriguing characteristic of B. thetaiotaomicron is its ability to upregulate 
the production of certain enzymes in relation to the availability of resources and 
environmental cues [59]. In a study conducted by Kotarski et al., they discovered that B. 
thetaiotaomicron did not produce a certain glycosyl hydrolase unless it was exposed to 
the substrate specific for the enzyme demonstrating the dependence between protein 
expression and carbohydrate availability [59–61].  
1.3.2 Polysaccharide Utilization Loci 
 Polysaccharide utilization loci (PULs) are clusters of genes that are involved in 
the breakdown of complex glycans [62]. PULs were initially described specifically for 
the starch utilization system (sus) in B. thetaiotaomicron however further experiments 
have shown upregulation of gene clusters accordingly to changes in the environment and 
carbohydrate variability other than starch [6]. PULs are made up of co-regulated proteins 
that interact with the carbohydrate substrate in a five-part systematic procedure. The 
general PUL system is comprised by:  (1) a protein located on the surface for substrate 
binding, (2) cleavage of complex sugars into more manageable lengths of 
oligosaccharides (3) the transportation of the oligosaccharides into the periplasmic space 
for (4) further degradation into monosaccharides, and finally (5) regulation of the PUL 
expression in response to carbohydrate availability and negative feedback from product 
saturation [63].  
1.4 Streptomyces coelicolor and Implications on the Rhizosphere 
Streptomyces coelicolor is a free-living soil bacteria and representative model 
species for the genus. S. coelicolor undergoes a unique morphological growth cycle 
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initiated by spore germination that develops into branched hyphae for substrate feeding, 
followed by the septation of reproductive aerial hyphae to produce spores to repeat the 
cycle [64,65]. As a ubiquitous species in soil, it has a significant role in contributing to 
the carbon cycle through vegetative decay and forms a close symbiotic relationship with 
plants for nutrient exchange. Rhizobacteria such as S. coelicolor densely populate the 
surroundings of plant roots because of the abundance of nutrients [66]. In return, 
rhizobacteria metabolize a variety of substrates including insoluble remains into useable 
carbohydrate sources to promote plant growth [67]. Understanding the relationship within 
the rhizosphere has been used to improve crop yields for agricultural purposes [68,69]. S. 
coelicolor are also found to produce a diversity of secondary metabolites with 
applications in human medicine such as anti-tumor and immunosuppressant drugs  
[65,70,71]. Interestingly, the production of such natural antibiotics were observed in 
correlation with increased carbohydrate metabolism indicating the importance of 
available carbohydrate substrates [72,73]. Additionally, S. coelicolor codes for anti-
microbial genes such as a type I ribosome-inactivating protein (SCO7092) with N-
glycosidase activity that was found to cleave a specific adenine residue from rRNA from 
ribose to prevent fungal ribosomal activity [74]. In general, studies of S. coelicolor 
revealed that the degradation of biopolymers was down-regulated when in the presence of 
glucose or other monosaccharides as a form of negative feedback to control catabolic 
activity [75]. The precise regulation in protein expression indicates an evolved system of 
carbohydrate metabolism by the bacterium.   
1.5 Research Objectives 
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The long term objectives of this project was to determine the structure and 
function of putative carbohydrate-active enzymes as provided by the CAZy database as 
open reading frames. Each potential open reading frame was analyzed and dissected into 
constructs of the catalytic domain and carbohydrate-binding domain. Characterized 
proteins will be added to the CAZy database as an access point for future studies in 
engineering biochemical uses and understanding the glycobiology of B. thetaiotaomicron 
and S. coelicolor.  
The first short term objective achieved was selecting potential open reading 
frames and running the sequences through a workflow of bioinformatics to predict 
putative characteristics or present carbohydrate-active domains of interest. From the 
CAZy database, the targets SCO6594-97 were selected while BT2857 was sent from Dr. 
Alicia Lammerts van Bueren of Gron Institute of Biomolecular Sciences & 
Biotechnology (Groningen, The Netherlands). Using bioinformatics and referencing to 
characterized proteins with high sequence similarity, target constructs were produced 
(Appendix I) for the downstream process of isolating and purifying recombinant, putative 
CAZymes. 
The second objective was to obtain precursor conditions that would lead to the 
determination of protein 3-D structure. The steps to achieving this objective required the 
screening of protein stability and crystal growth in a range of buffers, pH, additives, and 
temperatures. Once optimal crystal growth was obtained, diffraction would be performed 
for X-ray crystallography.  
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Finally, the last objective of the project was to determine the function of the 
protein through kinetic assays and substrate-binding. Experimental testing of potential 
substrates for the enzyme activity was drawn from extensive literature review. The 
bioinformatics workflow would also provide leads to active domains or catalytic residues 





CHAPTER 2 – EXPERIMENTAL TECHNIQUES FOR 
STUDYING THE STRUCTURE AND FUNCTION OF 
EXTRACELLULARLY-EXPRESSED PROTEINS 
2.1 Bioinformatics for Construct Design and Functional Hypotheses 
 The carbohydrate-active enzyme (CAZy) database is an essential starting 
point that indicates the hypothetical open reading frames that may code for enzymes 
partaking in carbohydrate metabolism and binding [76]. The list of hypothetical open 
reading frames are further organized into enzyme classes and families based on predicted 
domains and sequence similarity to existing characterized proteins. Using the sequence 
provided by National Centre for Biotechnology Information (NCBI), a series of 
bioinformatics resources will help predict the function and structure of the protein [77,78].  
STRING-10 provides a visual representation and interactive map of associated 
proteins with both structural and functional similarities surrounding the target protein 
thus leading to other prospective targets within the species’ genome [79]. InterPro is 
useful for predicting domains and important sequence-based features that might be 
present in the query sequence [80]. Domain predictions not only depict hypothetical 
structural folds, but also suggest possible functional activity. Additionally, Phyre
2
 
compiles a list of proteins with sequence similarity to the query which can help determine 
potential truncations sites when designing constructs for recombinant proteins [3]. This 
program also generates a predicted model based on high identity from similar proteins to 
the query indicating the confidence level of secondary structures. Open reading frames 
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that are predicted as extracellular proteins are prioritized because they are generally 
easier to express and isolate without the need to replicate particular in vivo conditions for 
protein folding and stability. SignalP 4.1 is a useful bioinformatics tool used to cleave 
any present signal peptide sequence from the query to prevent protein localization within 
the cell (such as transmembrane regions) when it is expressed [7]. Lastly, the PyMOL 
Molecular Graphics System, Version 1.8 Schrödinger, LLC is a visualization software 
used to display the predicted 3D structure using the protein database file (.pdb) provided 
by Phyre
2
 [3]. Other useful features of PyMOL include overlap of protein structures for 
comparison, modification and design elements to optimize presentation, and display of 
molecular interactions (i.e. electrostatic). Snapgene ® software (from GSL Biotech; 
available at www.snapgene.com) is used to view vector maps, restriction cute sites, and 
primer design. 
2.2 Protein Solubility Screening  
 To isolate expressed protein from cultures, the standard protocol solubilizes 
samples in 50mM Tris-HCl pH 7.5. However, if the protein is present in the pellet after 
chemical lysis, a quick alternative method to screen for protein solubility is sonicating 
cell pellets in different buffer conditions ranging from pH 4-10. Other variables for 
protein solubility include salt concentration, buffering agent, presence of urea, detergents 
(i.e. triton X-100, Tween-20, etc.) and/or glycerol. Sonication is a process of 
homogenization at ultrasonic frequencies (20kHz) by inserting a probe into the sample 
thus disrupting the cell membrane. The probe is connected to a generator which allows 
for control of frequency amplitude and pulse mode. Pulse mode is an important feature 
when homogenizing cell samples to prevent heat build-up and protein denaturation. 
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2.3 Methods of Protein Purification 
 Chromatographic techniques used throughout this study were immobilized-
metal (nickel) affinity chromatography (IMAC), anion-exchange chromatography, and 
size exclusion (or gel filtration) chromatography.  
 Nickel-IMAC is a method that captures recombinant proteins with a poly-
histidine tag (usually of six or more) attached to the N- or C-terminal. Resin beads are 
covalently attached to linker chains bound to nitrilotriacetic acid (NTA) which acts as a 
chelator to immobilize nickel ions. The free electrons from the nitrogen atoms of the 
histidine side group interact with the nickel ion by coordination hence the capture of 
recombinantly-tagged proteins. In theory, all remaining contaminant proteins without a 
histidine tag will flow through the column, past the nickel resin. However due to the large 
content of non-specific protein within the crude sample, protein-protein interactions are 
bound to occur therefore the resin is typically washed with a large volume of buffer 
containing 5mM of imidazole. To release the target protein from the resin, increasing 
concentration of imidazole is added because of its similar structure to histidine, imidazole 
will compete for the nickel sites. 
 Ion-exchange chromatography is a method that separates proteins based on 
their net charge. In anion-exchange, the column resin is positively charged and attracts 
proteins that are negatively-charged. The net charge of a protein can be manipulated to 
become negative-charged by suspending it in a buffer with a pH above its isoelectric 
point (pI). The release of protein from the column is achieved by introducing chloride 
ions (salt; NaCl) at increasing concentrations to compete for the positive sites.  
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 Finally, gel filtration is the process that separates proteins based on 
molecular mass. The packed resin is a porous matrix with varying molecular weight cut-
offs. In theory, larger proteins or proteins with larger hydrodynamic radii will flow 
through the column faster and elute first because they do not travel through the pores of 
the resin. Conversely, smaller proteins below the molecular weight cut-off will elute 
slower as they travel a longer distance through the pores of the resin.  
2.4 Electrophoretic Separation of Proteins with SDS-PAGE 
 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) is 
an electrophoretic technique used to separate a sample of proteins based on molecular 
weight. A typical SDS-PAGE gel will consist of a 4% stacking gel over-top a 12% 
resolving gel. The stacking gel is usually made at pH 6.8, while the resolving gel is made 
at pH 8.8. Both gels consist of a mixture of acrylamide and bis-acrylamide solutions that 
polymerize and form crosslinks with the addition of TEMED and APS. The purpose of 
the stacking gel is to initially line up the protein samples so that migration across the 
resolving gel occurs in uniform. Migration of the protein should run from the negatively 
charged cathode to the positively charged anode in the buffer system. Tertiary and 
quaternary structures of the protein is denatured and linearized with heat and the reducing 
agent, 2-mercaptoethanol, is useful for cleaving disulfide bonds. Proteins are then coated 
with SDS, giving them an overall negative charge to allow for migration across the gel 
using an electric current; higher molecular weight proteins will move slowly, while lower 
molecular weight proteins will be found close to the bottom because they move faster. 
Visualization of the proteins involves staining the gel with Coomassie stain and then de-
staining either with water or destaining solution. Heating up the stain and de-stain 
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solutions help decrease the time, otherwise the process may take from a few hours to 
overnight before proteins are visible on the gel.  
2.5 Spectral Properties of Proteins for Determining Concentration 
Fluorescence spectroscopy can be applied to study intrinsic and extrinsic 
fluorescent properties of a protein. The three residues used to measure intrinsic 
fluorescence are tryptophan, tyrosine, and phenylalanine with optimal absorption 
wavelengths at 280, 274, and 257nm, respectively. It is very common to measure 
fluorescence via tryptophan because it typically produces higher quantum yields due to 
overlapping absorption spectra with tyrosine and phenylalanine. To determine protein 
concentration, Beer’s Law is applied, where the predicted extinction coefficient is 
retrieved from inputting the protein sequence into the online bioinformatics tool, ExPASy 
ProtParam. The concentration units in M (mol/L) can be further converted into mg/mL 
given the calculated molecular weight of the protein (also from ExPASy ProtParam).  
2.6 Enzyme Kinetic Activity Measurement Using Spectroscopic Characteristics of 
Nitrophenol Release from the Substrate 
The kinetic rate and Michaelis-Menten variables can be determined for specific 
enzymatic activity through the cleavage of an artificial carbohydrate substrate with an 
attached nitrophenol moiety. This kinetic assay is particularly useful for enzymatic 
reactions such as glycoside hydrolases with mechanisms known to cleave apart sugars 
between the O-glycosidic bonds. The cleavage of a simple sugar (i.e. galactose, glucose, 
etc.) covalently bound to a nitrophenol group allows for colorimetric determination of 
activity as well as quantitative measurement by measuring the absorption at a wavelength 
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of 405nm. The artificial substrate is initially clear in color, but when nitrophenol is 
released it turns a yellow color due to the conjugated system from the resonant structure 
of the nitrophenolate ion. Consequently, the reaction is stopped with the addition of 
sodium hydroxide to alkaline pH to convert any remaining nitrophenol to its ionic form. 
The method not only allows for kinetic measurement, but also the determination of 
enzyme specificity to sugar linkages (i.e. ortho- or para- isomers). An assay can be easily 
set-up in a cuvette or microplate which allows for efficiency of producing replicate 
reactions for testing in a range of buffers with different pH values or varying 
concentrations of substrate over time. The kinetic rate of an enzyme can be calculated 
using the known extinction coefficient of nitrophenolate (18000 M
-1
 cm
-1) and Beer’s law 
(A = Ɛcl, where ‘A’ is absorption, ‘Ɛ’ is extinction coefficient of nitrophenolate, ‘c’ is 
concentration, and ‘l’ is path length).   
2.7 Site-Directed Mutagenesis of Potential Active Residues 
 To pinpoint the potential active residues that may reveal significant changes in 
kinetic activity of an enzyme, site-directed mutagenesis is used to produce such mutants 
with substitution of select amino acids. Complimentary primers should encompass the 
desired amino acid for substitution with approximately 15 base pairs flanking either ends 
of the codon for the selected amino acid. High-fidelity polymerases are typically used for 
these PCR reactions to allow full extension of the plasmid. The PCR product should also 
be treated with DpnI digestion to remove any parental methylated DNA that is leftover 
which also decreases the number of false positives when screening. Amino acids should 
be substituted with residues of similar R-groups (Ex: aspartate substituted with 
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asparagine) to prevent significant structural changes in the overall protein in order to 
investigate only kinetic changes.  
2.8 Examination of Protein Sample Distribution and Stability with Dynamic Light 
Scattering  
Dynamic light scattering is a non-invasive technique used to measure size 
distribution of particles in a sample including proteins. It can be used to distinguish 
particles with large differences in molecular mass in cases with protein that may form as 
monomers or dimers, or the presence of aggregation. A typical set up for analysis via 
DLS involves a laser or monochromatic light source that directs a beam towards the 
liquid sample contained in a microplate with a clear bottom and opaque sides to prevent 
reflective lighting. Upon contact of the incidental light beam with the sample, the 
wavelength of the refractive light will change as theorized using Brownian motion, which 
is the random motion caused by the collision of atoms or molecules. The change in 
frequency from the wavelength of the incoming light changes from the particle’s 
movement. Using the collected change in wavelength, the translational diffusion 
coefficient (a variable in the Stokes-Einstein relation) is used to solve for the diameter of 






D = diameter of particle, 
k = Boltzmann’s constant, 
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T = temperature, 
η = dynamic viscosity of the liquid/sample and, 
Dt = diffusion coefficient. 
Data collection from dynamic light scattering is also capable of computing 
molecular weight as well. The main prospect of this technique is population distribution 
to determine the purity within the sample after anion chromatography followed by 
crystallization to prevent formation of contaminant crystals or undesired precipitation if 
the protein happens to be unstable in particular mediums.  
2.9 Crystallization and Optimization for Diffraction 
The structure of a purified protein in crystal form can be determined by analyzing 
the diffraction patterns using X-ray crystallography. To first obtain such quality crystals 
for this method, a series of crystal trays must be setup to determine initial conditions to 
allow for crystallization; this typically requires a large selection of buffers and additives 
with varying conditions including pH, temperature, and concentration. Generally, the 
screening solutions of buffer and precipitants (collectively referred to as the ‘mother 
liquor’) is formulated in a reservoir, while the protein droplet is situated apart from the 
reservoir either on an inverted cover slip above the reservoir known as the ‘hanging drop’ 
method, or in a well raised above the reservoir known as the ‘sitting drop’ method. Over 
time, an exchange of vapor diffusion will occur between the protein drop and the 
reservoir to reach equilibrium and possibly reach crystallization. This method allows for 
a gentle and gradual process of dehydrating the protein droplet. Additionally, the protein 
droplet is usually mixed with varying ratios of mother liquor to aid with the eventual 
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equilibration. Successful crystallization outlines the packing of molecules in crystals with 
defined edges and three-dimensionality. Further crystal optimization from the initial 
screening involves tweaking the concentrations from the buffer conditions. Addition of 
carbohydrates that resemble potential endogenous substrates for the protein may also help 




CHAPTER 3 – MATERIALS, EXPERIMENTAL DESIGN 
AND METHODS 
3.1 Materials 
The cloning of target gene, BT2857 in vector p15TV-LIC, was sent to us in 
collaboration with Dr. Alicia Lammerts van Bueren (Faculty of Mathematics and Natural 
Sciences, Microbial Physiology) from Gron Institute of Biomolecular Sciences & 
Biotechnology (Groningen, The Netherlands). Custom gene orders for SCO6594-97 in 
vector pET21a(+)  were ordered from GenScript (Piscataway, NJ, USA). Competent 
NEB 5-alpha (catalogue #C2987) and BL21(DE3) (catalogue #C2527) E. coli cells were 
purchased from New England BioLabs Inc. (Ipswich, MA, USA). Novagen 
Tuner™(DE3)pLyss competent cells were purchased from EMB Millipore Corporation 
(Darmstadt, Germany). Restriction enzyme, Dpn I, CutSmart buffer, and Phusion® High-
Fidelity PCR Kit were also ordered from New England Biolabs Inc. All primers were 
ordered through Integrated DNA Technologies (Coralville, IA, USA).  
Tryptone powder, yeast extract, agar A, ammonium sulfate ((NH4)2SO4), tris, 
potassium phosphate (KH2PO4), sodium (dibasic) phosphate heptahydrate (Na2HPO4), 
sodium (monobasic) phosphate dehydrate (NaH2PO4), glucose, D-lactose, hydrochloric 
acid, ferric chloride (FeCl3),  calcium chloride (CaCl2), manganese chloride (MnCl2), 
zinc sulfate (ZnSO4), nickel (II) chloride (NiCl2), deoxycholic acid sodium salt, Triton X-
100, DNase I, sodium hydroxide (NaOH), sodium acetate trihydrate, urea, bromophenol 
blue, glycine, acetic acid (glacial), methanol, and D(+)-galactose were all purchased from 
BioBasic Canada Inc. (Markham, ON, Canada). Sodium chloride (NaCl), ampicillin 
sodium salt, glycerol, sucrose, lysozyme, magnesium chloride (MgCl2), imidazole, 2-(N-
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morpholino)ethanesulfonic acid (MES), ethylenediaminetetraacetic acid (EDTA), 
acrylamide 40% solution, tetramethylethylenediamine (TEMED), sodium dodecyl sulfate 
(SDS), Coomassie Brilliant Blue G-250, bis-tris methane, ethylene glycol were all 
purchased from BioShop Canada Inc. (Burlington, ON, Canada). Cobalt chloride (CoCl2), 
Tween-20, n-Dodecyl-β-D-maltoside (DDM), sodium citrate dihydrate, ammonium 
acetate, 4-Nitrophenyl β-D-galactopyranoside, 2-Nitrophenyl β-D-galactopyranoside, 4-
Nitrophenyl α-D-mannopyranoside, 4-Nitrophenyl α-D-glucopyranoside were all 
purchased from Sigma-Aldrich (St. Louis, MO, USA). JumpStart™ Taq ReadyMix™ 
and GenElute™ PCR Clean-Up Kit were also from Sigma-Aldrich.  
Cupric chloride (CuCl2) was from The British Drug Houses (BDH) and borrowed 
from Dr. DeBruin’s lab. Ethanol was purchased from Commercial Alcohols (ON, 
Canada). 2% Bis-2™ Solution (bisacrylamide) and polyethylene glycol 8000 were 
purchased from Amresco (Solon, OH, USA). HisPur™ Ni-NTA resin and SnakeSkin® 
dialysis tubing clips (green; 50mm) were purchased from ThermoScientific (Waltham, 
MA, USA). Dialysis tubing closures (white; 110mm) were also ordered from Sigma-
Aldrich. Ammonium persulfate, Fisherbrand® filter paper P4, and Fisherbrand® 
regenerated cellulose dialysis tubing were purchased from Fisher Scientific (Fair Lawn, 
NJ, USA). 2-Methyl-2,4-pentanediol was purchased from ACROS Organics (Geel, 
Belgium).  
Precision Plus Protein™ Dual Color Standards was purchased from Bio-Rad 
Laboratories Inc. (Hercules, CA, USA). The ENrich™ SEC 650 10 x 300 column for gel 
filtration was also purchased from Bio-Rad. Resource™ Q columns for anion-exchange 
chromatography was ordered from GE Healthcare (United Kingdom). Amicon® 
 24 
 
Ultracel®-10K regenerated cellulose centrifugal filters were purchased from Merck 
Millipore Ltd. (Germany). Microlytics MCSG1-4 crystal screen HT (1.7mL) were 
purchased from Anatrace (Maumee, OH, USA). Index Solution Set 1 reagents 1-48 
(catalogue #HR2-144) and Solution Set 2 reagents 49-96 (catalogue #HR-144) were 
purchased from Hampton Research (Aliso Viejo, CA, USA). 3-Inch wide crystal clear 
sealing tape (catalogue #HR4-506) and polyethylene glycol 3,350 flakes (catalogue 
#HR2-591) were also from Hampton Research. High vacuum grease was ordered from 
Dow Corning (Midland, MI, USA) and micro cover glass for crystal trays were ordered 
from VWR International (Radnor, PA, USA). Multiwell™ 24-well polystyrene non-
tissue culture treated flat bottom plates with low evaporation lids were ordered from 
Becton Dickinson (Franklin Lakes, NJ, USA) and INTELLI-PLATE® 96-well plates 
(catalogue #102-0001-03) were ordered from Art Robbins Instruments (Sunnyvale, CA, 
USA). Test (round-bottom) 96-well microplates were from Sarstedt (Montreal, QC, 
Canada).  
All the water used in this study was filtered with the Millipak®20 MQ Millipore 
purification system. All centrifugation steps were done using Beckman-Coulter 
(California,USA) rotors, ThermoScientific Sorvall™ Legend™ Micro 21centrifuge, 
and/or Fisher Scientific standard mini centrifuge. The Amsco® Lab 250 LV 250 
Laboratory Steam Sterilizer from Steris®(Mentor, OH, USA) was used for any autoclave 
treatment.   
3.2 Experimental Design and Methods 
3.2.1 Protein Expression and Isolation 
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Plasmids (BT2857) or custom genes (SCO6594-97) were transformed into 
BL21(DE3) E. coli competent cells. Transformations involved incubation of 1µL of 
plasmid with 50µL of competent cells in micro-centrifuge tubes on ice for half-hour, 
followed by heat shock at 42°C for 45 seconds, and placing them back on ice for 3 
minutes. 200µL of Luria-Bertani (LB) broth was added to the tubes and incubated at 
37°C for one hour at 240rpm. Transformations were then spread on ampicillin-resistant 
agar plates and incubated at 37°C overnight to allow for growth. The next day, a colony 
was picked from the plate and grown in 10mL of LB containing 100mM ampicillin at 
37°C overnight at 240rpm. The 10mL cultures were used to inoculate 2L of LB with 
100mM ampicillin and grown at the same conditions until they reached an OD600 of ~0.7. 
Overexpression of protein proceeded with the addition of isopropyl β-D-1-
thiogalactopyranoside (IPTG) and turning the temperature down to 16°C for overnight at 
the reduced speeds of 160rpm. Cells were harvested by centrifugation at 8000xg for 12 
minutes. Cell pellets were either stored at -20°C for later use or immediately treated with 
chemical lysis for protein isolation.  
For chemical lysis, cell pellets were re-suspended in one volume of sucrose 
solution for 10 minutes or until completely dissolved, followed by the addition of 
1mg/mL of lysozyme to mix for another 10 minutes. Two volumes of deoxycholate 
solution (50mM Tris-HCl pH 7.5) were added to stir for 10 minutes or until the mixture 
became a viscous consistency. 1M MgCl2 and DNase I solution was added and stirred for 
another 10 minutes. If the final mixture still appeared viscous, then a second chemical 
lysis was performed by repeating the above steps until the consistency became watery. 
Cell debris was separated from protein solution by centrifugation at 15000xg for 35 
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minutes. The pellet was assumed to consist of cell debris, while the supernatant was kept 
and assumed to be crude protein extract.  
In situations where the protein was insoluble and appeared in the pellet, 
sonication was performed to screen for solubility in different buffers instead of the 
standard 50mM Tris-HCl pH 7.5 in the deoxycholate solution. To do so, small samples of 
the cell pellet were divided into separate micro-centrifuge tubes and 1mL of buffer 
solution (with pH ranging from 3-10) was added. Samples were pulsed for 30 second 
intervals with amplitude of 40% and paused for 30 seconds inbetween to allow for 
cooling. All tubes were placed on ice during the sonication process to prevent protein 
denaturation. The sonicated solutions were centrifuged at 12000rpm for 10 minutes at 
room temperature, then the pellet and supernatant was run on SDS-PAGE to determine 
the condition/buffer in which the protein was soluble. The successful buffer was then 
replaced in the deoxycholate solution of the chemical lysis, or a large scale sonication 
protocol was used.  
Immobilized nickel affinity chromatography was preceded by incubating the 
crude protein extract with nickel-NTA resin in 50mL falcon tubes for 1 hour on ice or at 
4°C on a VWR rocking platform. The protein and nickel-NTA resin mixture was then 
poured into a glass Econo-column (Bio-Rad) and allowed to drain into a 250mL flask 
(labelled as ‘flow-through’). Once the resin settled evenly at the bottom of the column, 
50mL of wash buffer (50mM Tris-HCl pH 8, 5mM imidazole, 300mM NaCl) was added 
with care not to disrupt the resin and collected in a 50mL falcon tube (labelled as ‘wash’). 
Elution buffers contained increasing concentrations of imidazole (10, 25, 50, 75, 100, 200, 
300, 400, 500mM) and were each collected as 15mL fractions. The resin was cleaned 
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with one column volume of water, one column volume of NaOH, another column volume 
of water, and then stored in 20% (v/v) ethanol.   
3.2.2 SDS-PAGE 
To evaluate protein expression and isolation, the pellet (after lysis), crude protein 
extract, ‘flow-through’, ‘wash’ and all elution fractions were kept to run on SDS-PAGE. 
12µL of each fraction was mixed with 3µL of 5X SDS-PAGE sample buffer in micro-
centrifuge tubes. Each tube was heated at 95°C for 10 minutes, and then loaded into the 
SDS-PAGE gel alongside the Precision Plus Protein™ Dual Color Standards ladder. 
SDS-PAGE was run at 180V for 42 minutes or until the dye-front was 1cm from the 
bottom of the gel.  
Coomassie stain was added to the gel in a Tupperware container and heated for 30 
seconds in the microwave. The container was agitated for 30 seconds and the stain was 
poured back into its bottle through filter paper. Typically, water was used to de-stain the 
gel as visualization usually occurred almost immediately if a good yield of protein was 
present. Otherwise, de-staining solution was used and heated for 30 seconds in the 
microwave and agitated on the rocking platform until protein bands were present. The gel 
was imaged using Bio-Rad’s Molecular Imager VersaDoc™ MP 4000 System and 
Quantity One® software to manipulate and export images.    
3.2.3 Dialysis and Protein Concentration 
The SDS-PAGE gel was used to determine which elution fractions contained the 
least amount of contaminating bands (protein) while still containing the band for the 
target recombinant protein. The process of dialysis was to decrease the concentration of 
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imidazole in the sample to prepare it for other methods of protein purification. Dialysis is 
a gradual technique for removing imidazole through exchange of molecules between the 
sample and surrounding buffer by diffusion across the concentration gradient to reach 
equilibrium. All of the elution fractions that met this standard was pooled into one 
dialysis tubing bag and clipped at both ends to prevent leaking. The dialysis bag was 
submerged into a 2L beaker containing MQ water with a stir bar and was allowed to mix 
in the cold room (4°C) for 1 hour. Afterwards, the dialysis bag was transferred to another 
2L beaker containing 50mM Tris-HCl pH 8 and again was mixed in the cold room 
overnight. 
Protein concentration was performed using the Amicon® Ultracel®-10K 
regenerated cellulose centrifugal filters from Millipore. Before use, the filter was filled 
with MQ water and centrifuged at 4000xg for 3 minutes to wet the membrane. 
Subsequently, the filter was filled with protein sample and centrifuged at 4000xg for 10 
minutes using the Allegra X-14R centrifuge from Beckman Coulter, and was refilled with 
more protein sample between every interval. If the bottom of the sample in the filter 
appeared a brown colour, then a disposable pipette would be used to gently agitate the 
solution to re-suspend the concentration of protein. Typically, protein samples were 
centrifuged in the filters until they reached a concentration of at least 10mg/mL for 
crystal tray screening. For anion-exchange chromatography, the protein was not 
concentrated, and for gel filtration, the protein sample would need to be concentrated to 
~3mL.   
3.2.4 Purification Using Anion-Exchange Chromatography and Gel Filtration 
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Purification by anion-exchange chromatography was performed using protocols 
from the UNICORN 6.4 Workstation program to control the ÄKTA pure fast protein 
liquid chromatography (FPLC) system purchased from GE Healthcare (Missisauga, ON, 
Canada). All lines were primed with their respective buffers and solutions at a flow rate 
of 3ml/min until the UV signal at 280nm flat-lined to ensure no previous protein was left 
on the Resource™ Q column. The standard protocol for anion-exchange chromatography 
was selected and run with the sample protein. The wash buffer used for the system was 
50mM Tris-HCl pH 8, and the elution buffer used was 50mM Tris-HCl pH 8 with 1M 
NaCl. The elution gradient was set to increase from 0-100% of salt, leading to the gradual 
release of protein as the chloride ions competed for interaction with the column. The 
elutions were collected as 2mL fractions. The elution fractions that encompassed the peak 
with the greatest UV280 signal was run through SDS-PAGE to confirm the presence of the 
target protein. 
Purification by gel filtration depended on the quality of the protein sample after it 
was purified through nickel-IMAC and anion-exchange. If the sample appeared to 
contain contamination with a large enough difference in molecular weight to the target 
protein, then gel filtration was an appropriate choice for further purification. To prepare, 
the sample was concentrated to a volume of ~3mL and injected into the 1mL sample loop 
on the Bio-Rad NGC™ Chromatography System. The ChromLab™ software was used to 
control the load of sample onto the ENrich™ SEC 650 column, followed by the flow of 
wash buffer (50mM Tris-HCl pH 8) at a flow rate of 1mL/min. All elutions were 
collected as 1mL fractions. The elution fractions that encompassed the peaks with a 
UV280 signal was run through SDS-PAGE to determine the presence of the target protein.   
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40µL of each elution fraction was also loaded into a sterile 384-well black 
polystyrene plate with clear flat-bottom for DLS using the DynaPro PlateReader-II from 
Wyatt Technology(Santa Barbara, CA, USA). The DYNAMICS® software was used to 
analyze protein samples and indicate the purity of the particle population. Typical results 
would reveal a single peak of size distribution with low percentage of polydispersity 
indicating that the protein sample exists in a unimodal state. The calculated molecular 
weight might also be close to the predicted value depending on the shape of the protein 
(see section 2.8).  
3.2.5 Determining Protein Concentration 
The concentration of protein in a sample was determined by measuring the 
fluorescence of tryptophan residues at a wavelength of 280nm. First, the Genesys 10S 
UV-Vis spectrophotometer from ThermoScientific was blanked with MQ water 
contained in a quartz cuvette by Hellman® Analytics. To the same cuvette, 5µL of 
protein sample was added to the MQ water and mixed by inversion while covering the 
top with parafilm. The fluorescence spectra from 260-300nm was collected, but only the 
value at 280nm was used to calculate protein concentration. Beer’s law was used to 
calculate the protein concentration: 
𝐴 = 𝜀 ∙ 𝑐 ∙ 𝑙 
Where ‘A’ = absorbance, ‘Ɛ’ = extinction coefficient (M-1cm-1), ‘c’ = concentration (M), 
and ‘l’ = path length (cm). The path length of the cuvette was 1cm.  
By re-arranging the formula, the concentration in M (mol/L) can be isolated: 
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To convert the units of concentration (M) to mg/mL, the molecular weight of the 

















Also, the dilution factor must be taken into consideration: 




3.2.6 Crystal Screening and Expansion Plate Set-up 
96-well crystal trays for preliminary crystal screening were set-up using the 
automated Gryphon system to draw from a series of crystal screen conditions. The 
protein to reservoir ratios used for this sitting drop method was 1:1 and 1.5:1. All trays 
were sealed with clear tape and stored at 18°C. They were observed under a microscope 
after a day of incubation. Successful hits were noted on the scoring sheet for further 
optimization of crystal growth. 
Expansion trays were set up in 24-well plates using the hanging drop method. 
Each expansion tray was a compilation of the successful hits with slight changes in 
concentrations or additives to test for better crystal growth. Expansion trays were 
prepared by greasing the rims of each well with vacuum grease, followed by formulating 
the reservoir solution in each well. The lab bench was sterilized with ethanol before 
placing six glass cover slips on it. To each cover slip, the same ratio of protein to 
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reservoir droplet was produced but at larger volumes (e.g. 2µL of protein to 2µL of 
reservoir compared to the 0.2µL used in the 96-well plates). The top droplet was usually 
assigned as the 1:1 ratio, while the bottom droplet was 1.5:1. The placement of the 
droplets was also located closer to the center of the cover slip to prevent disruption from 
the vacuum grease or the well edges. The cover slip was then inverted and placed over 
the respective well with slight pressure applied to ensure the seal. The next row of six 
cover slips was set-up and steps were repeated until the entire tray was completed. The 
crystal tray was stored at 18°C and observed for crystals after an appropriate time period.  
3.2.7 Enzyme Kinetic Assays 
The kinetic activity of the enzyme was tested using para-nitrophenyl-type 
substrates for easy detection and quantification of reactions. All reactions were prepared 
in 96-well microplates and absorbance values collected with the Synergy HT Multi-Mode 
microplate reader from BioTek (Winooski, VT, USA). First, the pH profile of the enzyme 
was determined by incubating 1µL of 50nM enzyme with 10µL of 50mM para-
nitrophenyl β-D-galactopyranoside (PNP-Gal) in a range of buffers at different pH to a 
final volume of 100µL.  
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Table 5. List of buffers used for pH profile in enzyme kinetics. 
 
All reactions were performed in triplicate at room temperature (~25°C) and at 
37°C for 10 minutes. The optimal buffer, pH, and temperature for the enzyme reaction 
were used to continue with kinetic characterization. To produce the Michaelis-Menten 
curve, 1µL of 50nM enzyme was incubated with the substrate at increasing 
concentrations. Reactions were incubated for 15 minutes with absorbance collected every 
45 seconds.  
Buffer (50mM) pH 
Sodium citrate 3.0 
Sodium citrate 4.0 
Sodium citrate 5.0 












Table 6. Typical microplate set-up of enzyme kinetics for producing a Michaelis-
Menten curve. 
 
*All reactions were performed in triplicate. Final concentrations of substrates are 
indicated in brackets beside the volumes. Wells D1-D10 represents blanks.  
 
The rate (Abs/min) was calculated for each curve collected from each 
concentration of substrate. The unit of each rate was converted to M/min using Beer’s 
Well 
Volume of 50nM 
Enzyme (µL) 
Volume of 50mM 
Substrate (µL) 
Volume of Buffer 
(µL) 
A1A3 1 1 (0.5mM) 98 
A4A6 1 2 (1mM) 97 
A7A9 1 3 (1.5mM) 96 
A10A12 1 4 (2mM) 95 
B1B3 1 5 (2.5mM) 94 
B4B6 1 6 (3mM) 93 
B7B9 1 12 (6mM) 87 
B10B12 1 18 (9mM) 81 
C1C3 1 24 (12mM) 75 
C4C6 1 30 (15mM) 69 
D1 0 1 99 
D2 0 2 98 
D3 0 3 97 
D4 0 4 96 
D5 0 5 95 
D6 0 6 94 
D7 0 12 88 
D8 0 18 82 
D9 0 24 76 




Law and the Michaelis-Menten curve was plotted using MyCurveFit 
(https://mycurvefit.com/) (unless otherwise stated). The Michaelis-Menten variables, 






Where ‘Et’ = total enzyme concentration.  
3.2.8 Galactosidase Activity Confirmation 
Enzymes that were tested positive for activity with PNP-Gal were transformed 
into the Tuner(DE3)pLyss cells to re-confirm β-galactosidase activity. Tuner cells lack 
the presence of lacZ which codes for endogenous β-galactosidase. A notable 
disadvantage of Tuner cell is the significant decrease in protein expression, therefore a 
larger volume of cells must be cultured and harvested to reach the same yield as that 
produced by BL21(DE3) cells.  
3.2.9 Site-Directed Mutagenesis  
Two mutants of BT2857 were selected in attempt to elucidate active site residues. 
Primers were created using QuikChange Primer Design for the mutants, D208N and 
E311Q. Upon arrival, primers were re-suspended in nuclease-free water for a final 
concentration of 1mM. Working stocks of primers were prepared by further dilutions to 
final concentrations of 100uM. 
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Table 7. PCR reaction set-up for D208N mutant. 
 
Table 8. Thermocycler conditions used for PCR reactions. 
Step Temperature (°C) Time (s)  
Initial Denaturation 98 30  
Denaturation 98 10 
Repeat cycles 
34X 
Annealing 66.8-0.2°C/cycle 30 
Extension 72 210 
Final Extension 72 600  
 
PCR products were run on a 0.7% (w/v) agarose gel at 100V for 40 minutes with a 1kb 
NEB ladder for determining DNA size. Gels were imaged using the Molecular Imager 
VersaDoc™ MP 4000 System. PCR products that were observed around the correct size 
were treated with restriction enzyme, DpnI, to cleave any remaining parental DNA. The 
reaction was then cleaned using GenElute™ PCR Clean-Up Kit and transformed into 
NEB 5-alpha E.coli competent cells. Colonies were picked and grown in 10-mL cultures 
PCR Component Volume Added (µL) 
BT2857 plasmid (50-100ng/µL) 5 
5X HF Buffer 10 
10mM dNTPs 1 
Forward Primer (100uM) 1 
Reverse Primer (100uM) 1 
MgCl2 0.5 
DMSO 0.5 
Phusion polymerase 0.5 
Nuclease-free water 30.5 









CHAPTER 4 – BIOINFORMATIC REVIEW 
4.1 Model prediction and Functional Hypothesis for BT2857  
The protein sequence of BT2857 was run through a series of bioinformatics tools 
in order to a build a hypothesis on the structural and functional aspects of the protein. The 
sequence of BT2857 was inputted in TMHMM Server v. 2.0 to predict protein topology 
and whether the structure possessed any membrane-spanning domains (Figure 2) [1]. 
This was an important source of information for the expression of BT2857 and stability 
in solution.  
 
Figure 3. TMHMM Server v. 2.0 output for BT2857 [1]: A short peptide (red) is 
predicted to be located in the transmembrane, while the remaining sequence is found on 
the outside with a probability of 1 (pink) indicating that it is not a transmembrane protein.    
 
The output from TMHMM depicted that a small portion of the N-terminus of 
BT2857 was predicted to possess transmembrane components, however the probability is 
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considerably low (~0.2). The remainder of the protein was found to be located outside 
with a probability above 1 giving confidence that BT2857 was suggested to be targeted 
extracellularly. In the results, the expression and isolation of BT2857 reflected the output 
by TMHMM. InterPro was used to predict the presence of domains or repeats based on 
sequence similarity [80]. The only output from InterPro suggested a detailed signature 
match to a cysteine knot. Cysteine knots are made up of six cysteine residues that link to 
form active forms of protein dimers in growth factors. This prediction suggested that the 
structure of BT2857 might exist in a dimer form or possessed more than one domain. To 
validate the structural predictions, RaptorX and Phyre
2
 were used to produce models with 
characterized proteins of sequence similarity (Figure 3 and 4). Although both predicted 
models possessed low confidence in similarity with the listed output, the common 
structural aspect was observed in the beta-folds that may suggest a catalytic or substrate-
binding domain. IntFOLD and SWISS-MODEL were two other servers used to predict 
the structure of BT857 and were able to cover a larger range of the sequence to produce a 
more complete model (Figure 5 and 6).  
 
Figure 4. RaptorX predicted model of BT2857 based on template PDB ID:1EUT 
Chain A [2]: 100% of the input sequence was modelled based on the best template PDB 
ID: 1EUT. The structure is predicted as three domains forming barrel-like shapes and a 






 predicted model of BT2857 based on template PDB ID:1RHF, an 
immunoglobulin superfamily fold:  The model aligns with the N-terminal and covers 
21% of the query sequence with 14% confidence in similarity. Residues G36-V120 are 
modelled [3].  
 
The predicted models from IntFOLD and SWISS-MODEL provided better insight 
on the possible domains and position of active site residues within BT2857. Similar to the 
model from RaptorX, the output from IntFOLD predicted three distinct domains with 
beta-barrel like folds, while SWISS-MODEL only predicted two domains. The 
inconsistencies among models were most likely a result of low confidence and similarity 




Figure 6. IntFOLD predicted model of BT2857 based on template PDB IDs: 1W8N 
and 4LQR [4]: The predicted model had medium confidence level with a p-value of 
0.042. The input sequence displayed high values of residue error for the N-terminus (~1-
200) compared to the templates. Residue error is based on the distance (in Angstroms) of 
an atom to the alpha-carbon (Cα). The C-terminus also displayed peaks of high residue 
error indicating that the overall predicted model is not entirely accurate. The overall 
structure is predicted to be made of beta-strands that form three barrel-like domains. The 
N- (blue) and C- (red) terminal truncations are highlighted on the model.   
 
 
Figure 7. SWISS-MODEL predicted model of BT2857 based on template PDB ID: 
4BQC [5]: The alignment covers residues 33-212 with a  sequence similarity of 0.26 
highlighting only the predicted structure of the N-terminus is made of beta-strands.  
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To investigate functionality, BT2857 was discovered to be experimentally 
validated as part of the polysaccharide-utilization loci (PUL) that could be found on the  
CAZy database (Figure 7) [6,55]. The PUL distinguishes genes organized around the 
susC/D gene pair for the transport and breakdown of complex glycans in the 
Bacteroidetes species. Upon expression in various conditions, studies demonstrated that 
aside from BT2857, several other proteins were upregulated and predicted to behave as 
an operon for carbohydrate uptake and regulation.  
 
Figure 8. Experimentally validated upregulation of BT2854-59 as part of PUL 
labelled with putative functions: BT2858-59 are predicted to comprise of SusC and 
SusD domains used for carbohydrate transport into the cell. BT2856-57 remain unknown. 
BT2854 and BT2855 are predicted to belong to family of GH2 and 3, respectively. The 
known activity of the GH families are labelled below providing insight on potential 
substrates of the PUL [6]. 
 
Using the information from PUL, two characterized enzymes belonging to the gene 
cluster were revealed to have mannosidase and glucosidase activity, alluding to potential 
substrates to be tested with BT2857. Also, because B. thetaiotaomicron resides in the 
human gut, a series of endogenous substrates possessing mannose and glucose units were 
also possible substrates to be tested.  
4.2 Predicted Functional Roles of SCO6594-97 
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 Based on the cluster of S. coelicolor targets chosen, it was believed that 
SCO6594-97 may behave as a unit in carbohydrate metabolism much like a PUL for 
Bacteroidetes (Figure 8). Therefore the functional roles of SCO6594-97 were further 
investigated using a series of bioinformatics.  
 
Figure 9. Organization of predicted functional roles of SCO6594-97: The activities of 
SCO6594-97 are predicted using InterPro and indicate that SCO6596 and SCO6597 
comprise of domains belonging to GH family 2 and 3, respectively. The sequence 
prediction of SCO6594 resembles a pectin lyase fold where a majority of the structure is 
made of parallel beta-sheets. 
 
The predicted function and fold of SCO6594-97 was collected from InterPro 
suggesting possible mannosidase activity as well as carbohydrate recognition for either 
substrate binding or cell adhesion. Open reading frames were explored upstream and 
downstream of this “operon” however no other predictions were revealed. Due to the lack 
of information available on SCO6595 for conclusive predictions on the structure and 
function, the section was omitted below. InterPro output for SCO6595 predicted an 
unknown domain, however further analyses did not uncover and possible functional roles.  
4.2.1 Functional Predictions of SCO6594 
SignalP 4.1 server was one of the primary sources used to screen the target 
sequence for presence of a signal peptide when ordering custom genes [7]. Signal 
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peptides are undesirable for protein localization within the cell because isolating protein 
may pose a challenge for solubility. Output for SCO6594 indicated a cut-off signal 
around Asp47 shown by the spike in C- and Y-score above 0.5 (Figure 9). The construct 
for SCO6594 was designed with a cut-off at Tyr72 after combining the output from all 
the tools. Tyrosine was reasoned as the better starting residue for protein solubility rather 
than a charged aspartate residue.   
 
Figure 10. SignalP 4.1 output for SCO6594: The graph indicates a cut-off signal at 
Asp47 for removal of signal peptide indicated by the peak from the Y-score [7].  
 
InterPro results (not shown) indicated that SCO6594 possessed an N-terminal 
domain with beta-mannosidase activity and C-terminal pectin-lyase fold suggesting its 
role in the degradation of plant carbohydrate sources [80]. Lastly, Phyre
2
 predicted 
sequence similarity to a glucan 1,3-β-glucosidase and fructotransferase (Figure 10) [3]. 
The predicted model depicted a bulky protein with an abundance of beta-fold connected 
through loops. There was possibility that SCO6594 is made up of two domains, hence 
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another construct cleaving the sequence nearly in half from T72-V238 was designed to 




predicted model of SCO6594 based on sequence homology with a 
beta-1,3-glucanase from Phanerochaete chrysosporium: The template sequence 
demonstrated 100.0% confidence and 95% coverage to the input sequence. The predicted 
model comprises of parallel beta-strands. Residues S12-V594 are modelled [3]. 
 
4.2.2 Functional Predictions of SCO6596  
SignalP 4.1 output indicated the suggested cut-off signal at Ala42 which was 
taken into consideration when ordering custom genes [7]. BLAST was resourceful for 
indicating predicted domains based on sequence similarity to a database of unknown and 




Figure 12. Basic local alignment search tool (BLAST) search of SCO6596: Results 
indicate predicted domains of a cellulase-like superfamily on the N-terminus, and 
cadherin repeat and F5/8 type C domain towards the C-terminus [8].   
 
The BLAST search suggested a cellulase-like superfamily providing insight on 
cellulose and other similar carbohydrates as potential substrates (Figure 10) [8]. The 
cadherin repeat also suggested the requirement for calcium ions for protein activation or 
stabilization of interactions. Finally, the F5/8 type C domain did not reveal any 
predictions in overall SCO6596 function, but suggested the involvement in surface 
interaction or cell adhesion. Alternatively, InterPro was able to predict a glycoside 
hydrolase belonging to family 2 with galactose-binding domain uncovering more specific 
functions of SCO6596 in the hydrolysis of O-glycosyl compounds [80]. Phyre
2
 also 
revealed sequence similarity to various beta-galactosidases including from Arthrobacter 
sp. c2-2 and lacZ expressed as a protein from Escherichia coli (Figure 11). Truncations 
of SCO6596 were designed based on InterPro domain output and cross-referenced with 
Phyre
2






 predicted model of SCO6596 based on sequence homology with a 
beta-galactosidase from Arthrobacter sp. c2-2: The template sequence demonstrated 
100% confidence and 63% coverage of the query sequence from the N-terminus. 
Residues R10-V443 are modelled [3].  
 
4.2.3 Functional Predictions of SCO6597 
A BLAST search of the protein sequence of SCO6597 revealed predicted 
glycosyl hydrolase family 3 (GH3) on both N- and C-terminus [8]. The C-terminal GH3 
domain was also predicted to be involved in beta-glycan binding and catalysis. A 
fibronectin type III-like domain was also predicted at the C-terminal suggesting substrate 
recognition and binding. Output from InterPro also confirmed the prediction of a GH3 
domain on either terminus providing insight on SCO6597 possible function in the 
hydrolysis of O-glycosyl substrates [80]. Finally, Phyre
2
 revealed sequence similarity 
with a β-glucosidase from Kluyveromyces marxianus and Streptomyces venezuelae 






 predicted model of SCO6597 based on sequence homology with a 
beta-glucosidase from Kluyveromyces marxianus: The template sequence demonstrated 
100.0% confidence and 93% coverage of the query sequence. Residues I12-A857 are 
modelled [3].  
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CHAPTER 5 – RESULTS 
5.1.1 Expression and Purification of BT2857 
The first objective was to express the recombinant protein, BT2857, which was 
achieved in 2L cultures of LB supplemented with ampicillin. The cells were harvested 
and underwent chemical lysis to isolate the protein. Following centrifugation to separate 
the cell debris (pellet) and supernatant (crude protein extract), the supernatant was 
incubated with nickel beads to run through nickel-IMAC (Figure 13).  
 
Figure 15. SDS-PAGE gel depicting the isolation of BT2857 (~46kDa) from crude 
protein extract via nickel-IMAC: 12% SDS-PAGE gel loaded with the elution fractions 
of increasing imidazole concentrations of 5, 10, 25, 50, 75, 100, 200, 300, 400, and 
500mM  from lanes 2-11. Lane 1 was loaded with Precision Plus Protein™ Kaleidoscope 
ladder.   
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An initial attempt to use gel filtration on BT2857 was conducted by pooling 
together fractions 4-7 from the nickel-IMAC (see Figure 13) and concentrating to a 
volume of 3mL. Unfortunately, gel filtration did not yield clean purification as the next 
step because of the contaminating bands that can be found directly below, as well as a 
few contaminating bands found above the target protein bands (Figure 14).  
 
Figure 16. (Above) Chromatogram from gel filtration run, (Below) SDS-PAGE gel 
depicting the attempted purification of BT2857 (~46kDa) using gel filtration: 12% 
SDS-PAGE gel loaded with elution fractions from gel filtration. Lanes 2-7 were elution 
fractions A/9 to A/14 found under the peak of the chromatogram.. Lane 1 was loaded 
with Precision Plus Protein™ Kaleidoscope ladder.     
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Instead of using gel filtration, anion-exchange chromatography was attempted 
after nickel-IMAC instead which yielded better results (Figure 15). Correction to 




Figure 17. (Above) Example of chromatogram from anion-exchange 
chromatography, (Below) SDS-PAGE gel depicting the purification of BT2857 
(~46kDa) using anion-exchange chromatography: (Above) The chromatogram is an 
example of BT2857 run through anion-exchange and how defined the peak appears with 
little tailing indicating the mono-dispersity of the sample. The chromatogram is an 
example from another run and does not correlate with the SDS-PAGE gel below.  
(Below) 12% SDS-PAGE gel loaded with elution fractions collected from an anion-
exchange chromatography. Lane 4 was loaded with Precision Plus Protein™ 
Kaleidoscope ladder.   
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After successful purification of BT2857, the protein sample was concentrated in 
the centrifugal filters to a concentration of ~10mg/mL. A portion of the concentrated 
sample was used to prepare preliminary crystal trays for screening, while the leftover 
volume was used to test for kinetic activity. After a few days of incubation, the crystal 
trays were observed to show precipitation in many of the conditions indicating that the 
protein concentration might be too high or was unstable to crystallize as a full protein. 
After trial and error with decreased concentration, it was concluded that the protein was 
unable to crystallize due to the latter situation. Thus, the protein was truncated into N-
terminal and C-terminal domains based off predicted models of BT2857 from 
bioinformatics sources (Figure 5). As a result, both domains have been successfully 
expressed and purified to some extent (Figure 16 and 17).  
 
Figure 18. SDS-PAGE gel depicting the isolation of BT2857-N (~23kDa) using 
nickel-IMAC: 12% SDS-PAGE gel loaded with elution fractions of increasing imidazole 
concentrations (5, 5, 5, 10, 25, 50, 75, 100, and 500mM) in lanes 3, 5-12. The flow 
through and pellet were also run in lanes 1 and 2, respectively. The pellet indicates a 
large amount of protein that was not soluble perhaps dues to inadequate chemical lysis of 
the harvested cells or protein aggregation. Lane 4 was loaded with Precision Plus 
Protein™ Kaleidoscope ladder.   
 
                                                                         
      
      
      




Figure 19. SDS-PAGE gel depicting the isolation of BT2857-C (~20kDa) using 
nickel-IMAC: 12% SDS-PAGE gel loaded with elution fractions of increasing imidazole 
concentrations (5, 5, 5, 10, 25, 50, 75, 100, and 500mM) in lanes 2,3, 5-11. The flow 
through was loaded into lane 1. Lane 4 was loaded with Precision Plus Protein™ 
Kaleidoscope ladder.   
 
BT2857-N has been isolated through nickel-IMAC, while BT2857-C has been 
isolated with nickel-IMAC and purified using gel filtration (not shown). BT2857-C has 
been successfully crystallized at various conditions and is in the process of diffraction for 
X-ray crystallography. Crystal formation for BT2857-C initially started as thin platelets 
at a point of nucleation (can be observed in Figure 18, Middle image, towards top right 
corner of droplet), and later developed into more three-dimensional shapes (Figure 18, 
Bottom image, top of droplet).  
 
                                                                   
      
      
      
      




Figure 20. Crystal growth for BT2857-C from optimization trays: The crystallization 
of BT2857-C was achieved in the following conditions; (Above) 33mg/mL protein in 1% 
(v/v) glycerol, 0.1M sodium acetate pH 4.0, 17.5% (w/v) 3.35K PEG, 0.1M NaCl, and 
0.1M ammonium acetate, (Middle) 33mg/mL protein in 1% glycerol, 0.1M sodium 
acetate pH 4.0, 17.6% 3.35K PEG, 0.1M NaCl, and 0.1M ammonium acetate, and 
(Bottom) 33mg/mL protein in 2.5% glycerol, 0.1M sodium acetate pH 4.0, 18% 3.35K 
PEG, 0.1M NaCl, and 0.1M ammonium acetate. In the above condition, the formation of 
plate crystals are observed towards the center, however it is important to note the 3-
dimensionality of the crystal (seen in blue) that is angled on its side showing the 
thickness. The middle and bottom conditions also display crystals large enough for 
diffraction with 3-dimensionality.  
 55 
 
5.1.2 Kinetic Characterization of BT2857  
A series of kinetic activity trials were run with the remaining volume of purified 
BT2857. The first parameters to test for were the temperature and pH at which BT2857 
achieved optimal activity (Figure 19).  
 
Figure 21. pH Profile and temperature-dependence of BT2857 enzymatic activity on 
PNP-Gal: Optimal activity is observed with 50mM Tris-HCl pH 8.0 at 37°C. Kinetic 
activity for pH above 8 resulted in protein precipitation revealing protein instability in 
alkaline pH values.  
 
Once optimal conditions were determined for BT2857 kinetic activity, further 
reactions were prepared in triplicate for a Michaelis-Menten plot. Reactions with 
increasing concentrations of substrate were run in the microplate reader at 37°C for 15 





























Figure 22. Michaelis-Menten plot of BT2857 kinetic activity with PNP-Gal: From the 
equation of the curve, the Michaelis-Menten variable were calculated where Vmax = 
0.01994M/min, KM = 0.3660mM, and kcat = 6645 s
-1
. Data points were produced from a 
set of triplicates.  
 
BT2857 presented positive activity as a putative β-galactosidase on the substrate, 
PNP-Gal, meaning that the transformation into Tuner(DE3)pLyss competent cells was 
required. Protein expression by the Tuner strain displayed significant decrease in yield, 
however was still deemed a sufficient amount to test for kinetic activity (Figure 21). 
Protein was reportedly concentrated to 14.6 mg/mL (or ~320 µM), however the actual 
concentration of pure BT2857 was suspected to be much lower. The reported 
concentration accounts for BT2857 as well as contaminating protein that was still present 
in the sample as seen after one run of anion-exchange chromatography (Figure 22). 




















PNP-Gal Concentration (mM) 
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galactosidase activity expressed by lacZ should be removed by expression in Tuner cells 
thus extreme protein purity did not seem necessary. 
 
Figure 23. SDS-PAGE gel depicting the isolation of BT2857 expressed in 
Tuner(DE3)pLyss cells using nickel-IMAC: 12% SDS-PAGE gel loaded with the 
elution fractions of increasing imidazole concentrations of 5, 5, 5, 10, 25, 50, 75, 100, 
200, 300, 400, and 500mM  from lanes 3, 5-15. The flow through and pellet were also 
loaded into lanes 1 and 2, respectively. Lane 4 was loaded with Precision Plus Protein™ 
Kaleidoscope ladder. 
    
 
Figure 24. SDS-PAGE gel depicting the attempted purification of BT2857 
(expressed in Tuner(DE3)pLyss cells)) using anion-exchange chromatography: 12% 
SDS-PAGE gel loaded with elution fractions under the peak (chromatogram not shown) 
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in lanes 2-9. The elution fractions demonstrate the presence of contaminating bands 
therefore the purification was deemed unsuccessful. Lane 1 was loaded with Precision 
Plus Protein™ Kaleidoscope ladder.  
 
Figure 25. Michaelis-Menten plot of BT2857 expressed in Tuner(DE3)pLyss cells to 
confirm galactosidase activity with PNP-Gal: From the equation of the curve, the 
Michaelis-Menten variables were calculated where Vmax = 5.453e-7 ± 1.105e-8 M/min, 
KM = 1 ± 0.0832 mM, and kcat = 1.704e-3 s
-1
. Curve produced using the online curve-
fitting program ‘KM Vmax Tool Kit’ found on http://ic50.tk/kmvmax.html.  
 
 Despite various efforts to increase protein concentration of BT2857 expressed in 
Tuner cells, the same yield as expressed in BL21 was unachievable. However, low 
concentrations of BT2857 in Tuner cells still allowed for kinetic quantification as it did 
test positive for activity on PNP-Gal (after long periods of incubation compared to BL21) 
(Figure 23). The Michaelis-Menten variables obtained were much lower than when 
conducted in BL21 cells due to challenges in concentration, however the typical kinetic 
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trend could be observed where the rate of reaction leveled off at increased substrate 
concentrations (Vmax). 
Primers were ordered for two mutants, D208N and E311Q, of BT2857 to 
determine potential active site residues. The neutral analogous residues (asparagine and 
glutamine) were chosen to replace the respective charged residues (aspartate and 
glutamate) in hopes of revealing a decrease in kinetic activity. Therefore PCR reactions 
were set-up for site-directed mutagenesis of BT2857 (Figure 24). 
 
Figure 26. Agarose gel depicting PCR products for attempted trials of site-directed 
mutagenesis of BT2857: 0.7% (w/v) Agarose gel loaded with PCR products for site-
directed mutagenesis of D208N (lanes 1 and 2), and E311Q (lanes 3 and 4). PCR 
reactions and thermocycler conditions are listed in Table 3 and 4 (section 3.2.9 Site-
Directed Mutagenesis). Lane 1 was loaded with NEB 1kb DNA ladder.   
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The possible PCR hit for D208N was immediately treated with the restriction 
enzyme, DpnI, to remove any parental DNA. The plasmid was then transformed into 
NEB 5-alpha competent cells to ensure high efficiency uptake. Colonies were picked and 
cultured in 10mL of LB with ampicillin (final conc. 100mM). Cultures were mini-
prepped to isolate plasmid and sent to Robarts Research Institute (London, ON) for 
sequencing and confirmation of successful mutation (Appendix 4). Because BT2857 
confirmed β-galactosidase activity in the Tuner(DE3)pLyss cells, the D208N mutant was 
expressed in BL21 cells for better yields of protein and concentrated to approximately 20 
mg/mL. Due to time constraints, D208N activity was only roughly measured by 
incubating it with pNP-Gal at 37°C for 30 minutes. Some remaining BT2857 previously 
expressed in Tuner cells was incubated under the same conditions as the mutant as a 
positive control.    
 
Figure 27. Comparison in activity of BT2857 variants with PNP-Gal: The D208N   
mutant possesses the greatest activity with an absorbance reading of ~1.6, while BT2857 
expressed in Tuner(DE3)pLyss cells demonstrated little to no activity with varying 
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volumes of enzyme (due to extremely low concentration and possible denaturation of 
protein). 
 
5.2 SCO6594-97 Solubility Screen 
Upon arrival of custom genes for SCO6594-97, each gene was immediately 
transformed into BL21(DE3) competent E. coli cells and inoculated into 1L LB and 
ampicillin cultures for growth. Cells were harvested and a small portion was used for 
solubility screening by sonication to test which genes were expressed and readily soluble 
in the standard buffer condition (50mM Tris-HCl pH 7.5) used in chemical lysis. 
Sonications were performed on ice at 40% amplitude for 30 seconds of pulsing on and 30 
seconds of rest for a total of 3 minutes. Sonicated samples were centrifuged at 12000xg 
for 10 minutes and run on SDS-PAGE to assess expression and solubility (Figure 26 and 
27). It was difficult to differentiate target bands to the high levels of noise of 
contaminating bands on the gel, however SCO6584 showed potential indicated by an 
arrow. The pellet of SCO6597 (Figure 26 Lane 7) demonstrated a large expressed protein 




Figure 28. SDS-PAGE gel depicting the solubility screening of SCO6594 (~64kDa), 
SCO6596 (~63kDa), and SCO6597 (~89kDa) in 50mM Tris-HCl pH 7.5 via 
sonication: 12% SDS-PAGE gel loaded with the supernatant and pellet of sonicated 
samples with 50mM Tris-HCl pH 7.5. Lanes 2 and 3 were loaded with SCO6594 
supernatant and pellet, respectively. The black arrow indicates protein expression in the 
supernatant for SCO6594. Lanes 4 and 5 were loaded with SCO6596 supernatant and 
pellet, respectively. Lanes 6 and 7 were loaded with SCO6597 supernatant and pellet, 
respectively. Lane 1 was loaded with Precision Plus Protein™ Kaleidoscope ladder.   
 
Figure 29. SDS-PAGE gel depicting the solubility screening of SCO6595 (~39kDa) in 
various buffer conditions (see Table 5) via sonication: 12% SDS-PAGE gel loaded 
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with supernatant of SCO6595 after sonication in various buffer conditions and salt 
concentrations. The black arrow indicates the row at which SCO6595 is expressed and 
soluble in each condition. The best yield was observed in lane 3, 7, and 10 which 
corresponds to 50mM Tris-HCl pH 8.0, 50mM Sodium acetate pH 7.0 (300mM NaCl), 
and 50mM MES pH 7.0 (300mM NaCl), respectively. Lane 1 was loaded with Precision 
Plus Protein™ Kaleidoscope ladder. 
 
Table 9. List of Buffer Conditions Used in SCO6595 Solubility Screening (Table 
corresponds with Figure 28). 
  
 
5.3 Expression, Purification, and Kinetic Characterization of SCO6594 
SCO6594 demonstrated protein expression and solubility with the standard 
chemical lysis buffer, therefore it was selected as the first of the custom genes to be 
isolated for characterization. Isolation of SCO6594 proceeded with nickel-IMAC as 
previously used for BT2857 (Figure 28). Elution fractions were relatively clean off 
nickel-IMAC with some contamination seen right underneath the target bands. 
Lane Buffer Conditions 
2 50mM Tris-HCl pH 7.0, 300mM NaCl 
3 50mM Tris-HCl pH 8.0 
4 50mM Tris-HCl pH 8.0, 300mM NaCl 
5 50mM Sodium phosphate pH 7.0, 300mM NaCl 
6 50mM Sodium phosphate pH 8.0, 300mM NaCl 
7 50mM Sodium acetate pH 7.0, 300mM NaCl 
8 50mM Sodium acetate pH 8.0, 300mM NaCl 
9 50mM MES pH 7.0, 300mM NaCl 





Figure 30. SDS-PAGE gel depicting the isolation of SCO6594 (~64kDa) via nickel-
IMAC: 12% SDS-PAGE gel loaded with elution fractions of increasing imidazole 
concentrations (5, 5, 5, 10, 25, 50, 75, 100, and 500mM) in lanes 2, 4-11. Lane 1 was 
loaded with flow through, and lane 3 was loaded with Precision Plus Protein™ 
Kaleidoscope ladder. 
   
The fractions in lanes 4-8 of Figure 28 were pooled together for dialysis to 
decrease imidazole concentration in the pooled fractions. The collective protein sample 




Figure 31. SDS-PAGE gel depicting the purification of SCO6594 (~64kDa) through 
anion-exchange chromatography: 12% SDS-PAGE gel loaded with elution fractions 
that appeared  under the peak (chromatogram not shown) in lanes 1, 3-11. Lane 2 was 
loaded with Precision Plus Protein™ Kaleidoscope ladder.   
 
The successful purification of SCO6594 and subsequent concentration of the 
protein sample to ~11mg/mL lead to preliminary crystal tray set-up using the Gryphon 
against MCSG-2 (Microlytics), Index HR2-144 (Hampton Research) and Crystal Screen 
2 HR2-112 (Hampton Research) crystal screens. The remaining volume of concentration 
protein was used for kinetic testing, where it was crudely tested with PNP-Gal, ONP-Gal, 
and PNP-Man in a centrifuge tube to incubate at room temperature for 10 minutes. It was 
observed that the reaction with ONP-Gal exhibited greater activity (reaction turned dark 
yellow) than PNP-Gal (reaction turned light yellow), while the reaction with PNP-Man 
displayed zero activity (reaction remained colorless).  
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Similar to the initial kinetic testing with the pH profile that was conducted for 
BT2857, the same protocol was used for SCO6594 with the only difference being the 
substrate used was ONP-Gal instead of PNP-Gal  (Figure 30).  
 
Figure 32. pH Profile and temperature-dependence of SCO6594 kinetic activity with 
ONP-Gal: The kinetic activity begins to increase from pH 6.0, where to reaches optimal 
activity in 50mM Tris-HCl pH 8.0 at 37°C for SCO6594. The kinetic activity decreases 
thereafter and is completely absent at pH 10. Incubation at 37°C also yields greater levels 
of activity.  
 
Following the same protocol as previous, the kinetic characterization of SCO6594 
was performed in triplicate at the optimal buffer and temperature conditions of 50mM 
Tris-HCl pH 8 at 37°C. Reactions were set up in a microplate and incubated for 15 































Figure 33. Michaelis-Menten plot of SCO6594 kinetic activity with ONP-Gal: From 
the equation of the curve, the Michaelis-Menten variables were calculated where Vmax = 
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CHAPTER 6 – DISCUSSION 
6.1 Interpretation of BT2857 Kinetics 
The objective of the research project was the characterization of carbohydrate-
active enzymes. The target proteins that were taken on in this project were BT2857, 
SCO6594-97. Each protein required expression, isolation and purification before 
functional assays or crystal trays could be conducted to reveal functional or structural 
characteristics. BT2857 was successfully expressed and purified for kinetic 
characterization with the artificial substrate, 4-nitrophenyl β-D-galactopyranoside. From 
the Michaelis-Menten curve that was plotted, the Vmax = 0.019936M/min, KM = 
0.36598mM, and kcat = 6645.3 s
-1
 were calculated. The values calculated were slightly 
greater compared to literature values, where the reported kcat of endogenous β-
galactosidase in E. coli was determined to be 750 ± 30s
-1
 [81]. The reported KM of the 
endogenous β-galactosidase was also determined to be 0.12 ± 0.02mM [81], revealing a 
three-fold difference with BT2857. Even with the most active mutant produced in studies 
with endogenous β-galactosidase, the kcat and KM  values were not comparable to that of 
BT2857.  The difference in BT2857 activity with endogenous E. coli β-galactosidase 
activity might be that ONP-Gal was conducted in the study rather than PNP-Gal that was 
used with BT2857. Substrate variability can affect the kinetic rates of enzymatic activity 
due to favorable substrate-binding depending on substrate orientation and spacial 
geometry. The kinetic rates of BT2857 might also be slightly inflated because they were 
expressed in BL21(DE3) competent E.coli cells which possessed lacZ coding for 
endogenous β-galactosidase. Although isolation and purification steps performed on 
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BT2857 should somewhat prevent background activity of endogenous E. coli 
galactosidase, it was not completely guaranteed unless BT2857 is expressed in 
Tuner(DE3)pLyss cells. The kinetic rates obtained from BT2857 expressed in Tuner cells 
were much lower at what seems like negligible values mainly due to the suspected low 
concentration of protein obtained. The reported protein concentration was ~14.6 mg/mL 
however observation of the sample appeared a brown/yellow color which is atypical of a 
pure sample which was expected to be clear and colorless. However, when the sample 
was incubated with PNP-Gal, the color change to yellow was observed indicating that 
there was indeed catalytic activity. A negative control was also monitored alongside 
Tuner BT2857 to validate the color change was not from auto-hydrolysis of the substrate 
alone.  
6.2 Truncations of BT2857 for Crystal Growth and Site-Directed Mutagenesis 
Furthermore, the structural aspect of BT2857 was unattainable due to 
precipitation of protein even at concentrations below 10mg/mL when initial crystal trays 
were set-up. To overcome this challenge, BT2857 was truncated into N- and C-terminal 
domains. Analysis of the bioinformatics conducted on the sequence of BT2857 revealed 
little predictions in function and structure. Therefore, it was imperative to explore all 
general aspects of BT2857 to compile enough background for the hypothesis that 
BT2857 was a putative β-galactosidase that existed as two domains. InterPro, RaptorX, 
SWISS-MODEL, and IntFOLD were all consulted and suggested that BT2857 was 
composed of either two or three domains. Although evenly matched on output and 
confidence levels on the structure of BT2857, it was the two-domain hypothesis that held 
a greater percentage of similarity in sequence alignments. Two of the three domains that 
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were predicted from IntFOLD also demonstrated similarity with the two-domain 
hypothesis, while the third domain had low percentage in confidence. The active residues 
of each characterized protein with similarity to BT2857 from the query were compiled to 
predict appropriate truncation sites. The active residues within each characterized protein 
showed conservation of Asp92 and Trp290 [82,83]. A BLAST alignment was also 
conducted to predict any possible conserved residues, which is where the mutants D208N 
and E311Q for the study came to fruition. Although Asp92 and Trp290 came up as active 
residues, the placement of the residues on the predicted model of BT2857 was located in 
unusual areas outside of the two-domain model. Therefore, using the leads of each 
bioinformatics tool, the domain truncations were M24-T225 and E221-D398, which 
encompassed each active residue in each domain. The crystallization of the C-terminal 
domain of BT2857 was successful as a result of producing truncations of the protein 
(Figure 20). In hopes of splitting BT2857 into two domains, the active site could also be 
narrowed down, however in crude incubations of C-terminal and N-terminal isolated 
proteins there was activity present in both indicated by the color change to yellow with 
PNP-Gal. The D208N mutant was designed to explore potential catalytic residues, where 
the removal of the charged side group of aspartate would remove or lower activity. At a 
protein concentration of ~20 mg/mL, D208N activity was quantified with an absorbance 
reading of ~1.6 which is comparable to wild-type BT2857 readings of ~0.7 at a protein 
concentration of ~10 mg/mL. Therefore, it was concluded that Asp208 did not have a role 
in catalysis.      
6.3 Interpretation of SCO6594 Kinetics 
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The solubility screen performed on SCO6594-97 through sonication revealed that 
SCO6594 was readily soluble in the supernatant of the standard chemical lysis buffer. 
Even when SCO6594 was found to be soluble in 50mM Tris-HCl pH 7.5, it was purified 
in 50mM Tris-HCl pH 8.0 which displayed no changes in protein stability. Following up 
with kinetic characterization of SCO6594 revealed that the enzyme’s optimal condition 
was at 50mM Tris-HCl pH 8.0 at 37°C with the artificial substrate, 2-nitrophenyl β-D-
galactopyranoside. From the Michaelis-Menten curve that was plotted, the Vmax = 
0.007966M/min, KM = 0.6451mM, and kcat = 2655.3 s
-1
 were calculated. These values 
compared to the literature values of endogenous E. coli β-galactosidase with the same 
artificial substrate were also considerably greater, with an almost four-fold difference in 
kcat values [81]. As discussed, the kinetic rates of SCO6594 may have appeared inflated 
due to expression in BL21(DE3) competent E. coli cells coding for endogenous β-
galactosidase. No structural characteristics of SCO6594 have been elucidated, however 
the notable difference in enzyme activity between 2-nitrophenyl β-D-galactopyranoside 
and 4-nitrophenyl β-D-galactopyranoside of SCO6594 suggest a favorable interaction 
with the ortho-isomer and perhaps geometry of substrate fit to the active site.  
6.4 Solubility of SCO6595-97 
The solubility screen also revealed that SCO6595 was soluble in various buffer 
conditions. The best yield was observed in 50mM Tris-HCl pH 8.0, 50mM Sodium 
acetate pH 7.0, 300mM NaCl , and 50mM MES pH 7.0, 300mM NaCl. Although there 
was no common component among the three conditions, the pH does not differ greatly 
indicating the stability of SCO6594 in pH 7-8. The presence of sodium chloride also does 
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not interfere with protein solubility; however it is a preferable that the protein is soluble 
in sodium chloride for increased stability [84].  
Expression of SCO6596 was observed in neither pellet nor supernatant; therefore 
expression trials should be conducted to track protein expression after induction with 
IPTG. SCO6597 might possibly be expressed in the pellet where a prominent band 
appears around 100kDa. Although the observed band is considerably larger than the 
expected molecular weight of SCO6597 (~89kDa), the SDS-PAGE gel was run 
inconsistently which may impact the alignment of sample to the ladder. A second 
solubility screen with the presence of various metals could be run with SCO6596 and 
SCO6597 to identify the buffer condition with adequate yield for protein characterization. 
Protein expression may be improved by testing in different growth mediums such as 
Terrific Broth (TB) or Super Optimal Broth with Catabolite repression (SOC). TB differs 
from LB for containing glycerol, and SOC contains traces of KCl, MgCl2, and glucose.           
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CHAPTER 7 – CONCLUSIONS AND FUTURE STUDIES 
Bioinformatics tools had predicted that BT2857 possessed a galactose-binding 
domain, however it was unclear whether it was simply a carbohydrate-binding domain or 
if it was a domain as part of an enzyme. Through the kinetic characterization, it has been 
discovered that the enzyme is active with the artificial substrate 4-nitrophenyl β-D-
galactopyranoside thus partially elucidating the functionality of BT2857 as a putative β-
galactosidase. The Vmax = 0.019936M/min, KM = 0.36598mM, and kcat = 6645.3 s
-1
 was 
calculated using the Michaelis-Menten equation. Future research in the potential active 
residues of BT2857 is needed to determine the mechanism of kinetic activity. Piecing 
together the crystal structures of both N- and C- terminals will also aid in visualizing 
enzyme-substrate interactions.  
The preliminary steps have been conducted in revealing the expression and 
solubility of SCO6595-97, while kinetic characterization has been established for 
SCO6594. The Vmax = 0.007966M/min, KM = 0.6451mM, and kcat = 2655.3 s
-1
 was 
calculated using the Michaelis-Menten equation. Similar to the complete structural and 
functional protocols in the characterization of BT2857, the same process for future 
studies should be implemented with SCO6594-97.  
Future studies for the collaborative project of protein structure and function 
characterization also include thin-layer chromatography for predicted substrates. UV-
difference is also another procedure that could be conducted to investigate carbohydrate-
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APPENDICES   
Appendix 1: Full List of Target Proteins with Truncation Sites and Predicted Domains 
 
 
Construct(s) of Predicted Domains 
Streptomyces coelicolor  
SCO6594 T72 – V594 (Signal peptide removed) 
T72 – V238 (β-mannosidase) 
SCO6595 M1 – P360 (Full ORF) 
SCO6596 R10 – V443 (Signal peptide removed) 
V45 – G345 (GH3/42 family domain) 
V45 – V443 (GH3/42 family and galactose-binding 
domain) 
SCO6597 L15 – A857 (Signal peptide removed) 
L364 – A857 (GH3 family domain) 
Bacteroides thetaiotaomicron  
BT2857 M1 – E401 (Full ORF) 
M24 – T225 (N-terminus) 





Appendix 2: List of Bioinformatics Tools 










List of hypothetical CAZymes 
Links to characterized protein under 
enzyme classes and families 
http://www.cazy.org/  
BLAST Runs query against sequence databases to 






Computes molecular weight, theoretical 
pI, amino acid composition, extinction 






 Runs query to find protein homology and 




STRING Interactive map of predicted functional 







SignalP Distinguished predicted localization of 
protein with presence of signal peptide 
http://www.cbs.dtu.dk/service
s/SignalP/  
Interpro Predicts domains, families, or motifs by 
comparison of signature sequences 






Appendix 3: List of Primers for Site-Directed Mutagenesis of BT2857 
D208N 
Forward Primer 5’- AAATATGGGAATGAGACAAATACGCTGTTCACCGAGC -3’ 
Reverse Primer 5’- GCTCGGTGAACAGCGTATTTGTCTCATTCCCATATTT -3’ 
E311Q 
Forward Primer 5’- GCCCGAGACGCTACCAGGTATGGGGATGCGC -3’ 





Appendix 4: Sequencing Results for BT2857 D208N Mutant 




Appendix 5: pET21b(+) Vector with XhoI and NdeI Cut Sites Labelled for Insertion of 











Appendix 7: Crystal Diffraction Pattern and Index for BT2857-C  
 
 
